Skip to Main Content

NISH (NITAG Support Hub) 7: Mpox vaccines: Domain 7: Feasibility OR Vaccine Supply

This Library Guide is a collection of useful documents & evidence on the efficacy, effectiveness and impact of MPox vaccines to support NITAG members and other policy makers throughout Africa with making evidence-based recommendations.

Keywords

Mpox AND feasibility OR “successful implementation” OR “financial barriers” OR “vaccine supply” OR “vaccine use”

Google Scholar

Abubakar, I., Lutwama, J., Kyobutungi, C., & Sankoh, O. (2024). Mpox global emergency: strengthening African leadership. The Lancet, 404(10460), 1286-1288

Hrynick, T., & Schmidt-Sane, M. (2024). Roundtable report: Discussion on mpox in DRC and social science considerations for operational response. https://opendocs.ids.ac.uk/articles/report/Roundtable_Report_Discussion_on_mpox_in_DRC_and_Social_Science_Considerations_for_Operational_Response/26434924?file=48184294

Olawade, D. B., Wada, O. Z., Fidelis, S. C., Oluwole, O. S., Alisi, C. S., Orimabuyaku, N. F., & David-Olawade, A. C. (2024). Strengthening Africa’s response to Mpox (monkeypox): insights from historical outbreaks and the present global spread. Science in One Health, 100085.https://doi.org/10.1016/j.soh.2024.100085

Sinumvayo, J. P., Munezero, P. C., Tope, A. T., Adeyemo, R. O., Bale, M. I., Mutsaka-Makuvaza, M. J., ... & Adedeji, A. A. (2024). Vaccination and vaccine-preventable diseases in Africa. Scientific African, e02199.https://doi.org/10.1016/j.sciaf.2024.e02199

Kavey, R. E., & Kavey, A. (2024). Viral Pandemics: From Smallpox to COVID-19 & Mpox. Taylor & Francis.

Mazzotta, V., Lepri, A. C., Matusali, G., Cimini, E., Piselli, P., Aguglia, C., Lanini, S., Colavita, F., Notari, S., Oliva, A., Meschi, S., Casetti, R., Mondillo, V., Vergori, A., Bettini, A., Grassi, G., Pinnetti, C., Lapa, D., Tartaglia, E., Gallì, P., … Mpox Vaccine Lazio Study Group (2024). Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection: prospective cohort study. EClinicalMedicine, 68, 102420. https://doi.org/10.1016/j.eclinm.2023.102420

Feehan, J., Sah, R., Mehta, R., Byanga, K., Anand, K., Krsak, M., Al-Tawfiq, J. A., Henao-Martínez, A. F., & Apostolopoulos, V. (2024). Urgent call for vaccine supply to Africa amid ongoing Mpox clade I outbreak: addressing a public health emergency of international concern. Therapeutic advances in infectious disease, 11, 20499361241290965. https://doi.org/10.1177/20499361241290965

Rahim, F. O., Fallah, M., Jain, U., Richardson, E. T., Ndembi, N., Ngongo, N., & Kaseya, J. (2024). Challenges and Ongoing Actions to Address the Mpox Emergency in Africa. Annals of global health, 90(1), 68. DOI: 10.5334/aogh.4580

Guagliardo, S. A. J., Kracalik, I., Carter, R. J., Braden, C., Free, R., Hamal, M., Tuttle, A., McCollum, A. M., & Rao, A. K. (2024). Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine - United States, May 2022-May 2024. MMWR. Morbidity and mortality weekly report, 73(20), 460–466. DOI: 10.15585/mmwr.mm7320a3

Adepoju P. (2024). African mpox surges show lack of vaccine access. Lancet (London, England), 404(10447), 18. DOI: 10.1016/S0140-6736(24)01393-X